1. Home
  2. GNFT vs BETR Comparison

GNFT vs BETR Comparison

Compare GNFT & BETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • BETR
  • Stock Information
  • Founded
  • GNFT 1999
  • BETR 2014
  • Country
  • GNFT France
  • BETR United States
  • Employees
  • GNFT N/A
  • BETR N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • BETR Finance: Consumer Services
  • Sector
  • GNFT Health Care
  • BETR Finance
  • Exchange
  • GNFT Nasdaq
  • BETR Nasdaq
  • Market Cap
  • GNFT 202.6M
  • BETR 167.4M
  • IPO Year
  • GNFT 2019
  • BETR N/A
  • Fundamental
  • Price
  • GNFT $3.83
  • BETR $11.28
  • Analyst Decision
  • GNFT Strong Buy
  • BETR
  • Analyst Count
  • GNFT 1
  • BETR 0
  • Target Price
  • GNFT $13.00
  • BETR N/A
  • AVG Volume (30 Days)
  • GNFT 12.6K
  • BETR 27.1K
  • Earning Date
  • GNFT 04-03-2025
  • BETR 03-27-2025
  • Dividend Yield
  • GNFT N/A
  • BETR N/A
  • EPS Growth
  • GNFT N/A
  • BETR N/A
  • EPS
  • GNFT 0.47
  • BETR N/A
  • Revenue
  • GNFT $86,225,222.00
  • BETR $85,783,000.00
  • Revenue This Year
  • GNFT $145.20
  • BETR N/A
  • Revenue Next Year
  • GNFT N/A
  • BETR N/A
  • P/E Ratio
  • GNFT $7.98
  • BETR N/A
  • Revenue Growth
  • GNFT 175.45
  • BETR N/A
  • 52 Week Low
  • GNFT $3.35
  • BETR $7.71
  • 52 Week High
  • GNFT $6.42
  • BETR $30.00
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 48.44
  • BETR 53.47
  • Support Level
  • GNFT $3.69
  • BETR $10.69
  • Resistance Level
  • GNFT $4.03
  • BETR $12.44
  • Average True Range (ATR)
  • GNFT 0.16
  • BETR 0.82
  • MACD
  • GNFT -0.00
  • BETR 0.00
  • Stochastic Oscillator
  • GNFT 24.59
  • BETR 54.72

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About BETR Better Home & Finance Holding Company

Better Home & Finance Holding Co is a digital-first homeownership company whose services include mortgage, real estate, title, and homeowners insurance. The company has combined technology innovation and fresh thinking with a deep customer focus with the goal of revolutionizing the homeownership industry.

Share on Social Networks: